| Protocol No. | Title |
| ECOGTHOE1505 | A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (>=4 cm)-IIIA Non-Small Cell Lung Cancer (NSCLC). |
| ECOGTHOE1505-M | A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (> or = 4 cm)- IIIA Non-Small Cell Lung Cancer (NSCLC) |
| ECOGTHOE1508 | A Randomized Phase II Study of Cisplatin and Etoposide In Combination with Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients with Extensive Stage Small Cell Lung Cancer |
| ECOGTHOE4508 | Three-Arm Randomized Phase II Study of Carboplatin and Paclitaxel in Combination with Cetuximab, IMC-A12 or Both for Advanced Non-small Cell Lung Cancer Patients Who Will Not Receive Bevacizumab-based Therapy |
| PRECOGTHO0501-M | A Randomized Phase II Study Evaluating Vandetanib (ZD6474) in Combination with Doecetaxel and Carboplatin+/-Placebo or Maintenance Therapy with Vandetanib in Patients with IIIb, IV, or Recurrent Non-Small Cell Lung Cancer |
| VICCTHO0136 | Molecular Fingerprinting of Lung Cancer (SPORE) |
| VICCTHO0373 | Identification and Validation of Molecular Markers in Lung Cancer (SPORE) |
| VICCTHO0398 | Molecular Predictors of Lung Cancer Behavior. (SPORE) |
| VICCTHO0547 | Molecular Fingerprints in Lung Cancer: Predicting Tumor Response to Therapy (SPORE) |
| VICCTHO0640 | A Phase II Multi Center Study Investigating Translational Science in Chemotherapy-Naive Patients with Stage IIIb or IV Non-Small Cell Lung Cancer (NSCLC) treated with the EGFR-TKI, Erlotinib (SPECS) (SPORE) |
| VICCTHO0730 | A Phase II Trial of Celecoxib plus Chemotherapy [Docetaxel or Pemetrexed] in Patients with Previously Treated, "COX Dependent" Recurrent Non-Small Cell Lung Cancer (SPORE) |
| VICCTHO0734 | Molecular Predictors of Lung Cancer Behavior: Controls (SPORE) |
| VICCTHO0746 | A Phase I/II Study of Nab-Paclitaxel and Carboplatin with Concurrent Radiation Therapy for Unresectable Stage III Non-Small-Cell Lung Cancer (NSCLC) |
| VICCTHO0772 | A Phase I/II Study of RAD001 and Radiation Therapy in Patients with Brain Metastasis from Non-small Cell Lung Cancer (NSCLC) |
| VICCTHO0879 | Airway Gene Epithelial Cell Gene Expression in the Diagnosis and Treatment of Lung Cancer. |
| VICCTHO0909 | A Phase 1/2 Study of the Vascular Disrupting Agent NPI-2358 in Combination with Docetaxel in Patients with Advanced Non-Small Lung Cancer. |
| VICCTHO0920 | Phase II Study of Second-Line Bendamustine in Relapsed or Refractory Small Cell Lung Cancer (SCLC). |
| VICCTHO0938 | Survey and Blood Sample Collection for Patients with Lung Cancer Who Never Smoked Cigarettes. |
To find out more about clinical trials, call our Cancer Information Program nurses: